Confirmed Control (3%) Closed Transaction verified CPGSkincareSupplementsVitaminsVitamins & SupplementsWellness Products

Swisse acquired by Biostime

Biostime acquired Swisse, an Australian vitamins & supplements brand, on Sep 17, 2015.

Transaction summary

Target
Swisse
Acquirer
Biostime
Seller
-
Announced
2015-09-17
Geography
Australia
Tags
CPGSkincareSupplementsVitaminsVitamins & SupplementsWellness Products
Type
Acquisition
Deal type
Control
Stake acquired
3%
First added
2026-06-19
Latest update
2026-06-19

Value and multiples

Price / value

USD 1.7B

Consideration | USD

Basis: Public source

Price / revenue

-

Period not stated

Basis: FundComb estimate

Price / EBITDA

15.5x

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • USD 1.7bn consideration is treated as publicly disclosed or derived directly from public source data.
  • Price / EBITDA: 15.5x.
  • EBITDA and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
  • EBITDA basis was not stated in the source material.

Source summary

No public source summary has been published for this transaction yet.